Aspiriant LLC’s Hudson Technologies HDSN Stock Holding History

Aspiriant LLC’s Portfolio HDSN Stock Details HDSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-13,950	Closed	-$10K	–	187
2020 Q1	$10K	Buy	+13,950	New	+$11.1K	﹤0.01%	185

Other funds holding HDSN

CCPM

Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

PHS

Pekin Hardy Strauss Chicago, Illinois $957M AUM 44.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCM

Marathon Capital Management Hunt Valley, Maryland $445M AUM 26.09% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AWW

Alan W. Weber $336M AUM 75.94% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aspiriant LLC's HDSN Position: Q2 2020 in Review

Aspiriant LLC sold out of Hudson Technologies (HDSN) in Q2 2020, closing a stake of 13,950 shares — an estimated $10K sold.

Aspiriant LLC first reported a position in HDSN in Q1 2020 and held it in 1 quarter. The position peaked at $10K in Q1 2020. 32 funds tracked by Wall St. Rank hold HDSN as of Q2 2020.

Aspiriant LLC reported no remaining Hudson Technologies position as of Q2 2020 after selling out during the quarter.
Aspiriant LLC sold 13,950 Hudson Technologies shares in Q2 2020, an estimated $10K.
Aspiriant LLC first reported a position in Hudson Technologies in Q1 2020 and held it in 1 quarter.
Aspiriant LLC's Hudson Technologies position peaked at $10K in Q1 2020.
32 funds tracked by Wall St. Rank held Hudson Technologies as of Q2 2020.

Based on Aspiriant LLC's 13F filing for Q2 2020, filed 6 Aug 2020.